Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
REACH
5,11,17,23,29,35,41,47-octa-tert-butyl-49,50,51,52,53,54,55,56-octahydroxy-2λ⁶,8λ⁶,14λ⁶,20λ⁶,26λ⁶,32λ⁶,38λ⁶,44λ⁶-octathianonacyclo[43.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹.1²¹,²⁵.1²⁷,³¹.1³³,³⁷.1³⁹,⁴³]hexapentaconta-1(49),3,5,7(56),9,11,13(55),15,17,19(54),21(53),22,24,27,29,31(52),33,35,37(51),39(50),40,42,45,47-tetracosaene-2,2,8,8,14,14,20,20,26,26,32,32,38,38,44,44-hexadecone; 5,11,17,23-tetra-tert-butyl-25,26,27,28-tetrahydroxy-2λ⁶,8λ⁶,14λ⁶,20λ⁶-tetrathiapentacyclo[19.3.1.1³,⁷.1⁹,¹³.1¹⁵,¹⁹]octacosa-1(25),3,5,7(28),9,11,13(27),15(26),16,18,21,23-dodecaen-2,2,8,8,14,14,20,20-octone
EC number: 481-490-7 | CAS number: -
Toxicological information
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07-21 October 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD and EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Reaction mass of 5,11,17,23-tetra-tert-butyl-25, 26, 27, 28-tetrahydroxy- 2,8,14,20-tetrasulfonyl [19.3.1.13,7.19,13.115,19]octacosa- 1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene and 5,11,17,23,29,35,41,47-octa-tert-butyl- 49,50,51,52,53,54,55,56-octahydroxy-2,8,14,20,26,32,38,44- octasulfonyl[43.3.1.13,7.19,13.115,19.121,25.127,31.133,37.1 39,43]hexapentaconta- 1(49),3,5,7(56),9,11,13(55),15,17,19(54),21,23,25(53),27,29, 31(52),33,35,37(51),39,41,43(50),45,47-tetracosaene
- IUPAC Name:
- Reaction mass of 5,11,17,23-tetra-tert-butyl-25, 26, 27, 28-tetrahydroxy- 2,8,14,20-tetrasulfonyl [19.3.1.13,7.19,13.115,19]octacosa- 1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene and 5,11,17,23,29,35,41,47-octa-tert-butyl- 49,50,51,52,53,54,55,56-octahydroxy-2,8,14,20,26,32,38,44- octasulfonyl[43.3.1.13,7.19,13.115,19.121,25.127,31.133,37.1 39,43]hexapentaconta- 1(49),3,5,7(56),9,11,13(55),15,17,19(54),21,23,25(53),27,29, 31(52),33,35,37(51),39,41,43(50),45,47-tetracosaene
- Details on test material:
- - Name of test material (as cited in study report): TC4ASO2
- Substance type: multi-constituent
- Physical state: white powder
- Analytical purity: 100%
- Composition of test material, percentage of components: 95% 4-tert-Butylsulfonylcalix(4)arene (CAS 204190-49-8)
5% 4-tert-Butylsulfonylcalix(8)arene
- Lot/batch No.: AYUI-2Y
- Expiration date of the lot/batch: 08 July 2009
- Stability under storage conditions: Stable
- Storage condition of test material: At room temperature in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation: approx. 8 weeks old
- Weight at study initiation: males: 234-261 g; females: 166-176 g
- Fasting period before study: no
- Housing: Individually housed in labeled Macrolon cages (MIII type, height 18 cm)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.8 – 21.2
- Humidity (%): 43 - 72
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: To:
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- propylene glycol
- Details on dermal exposure:
- TEST SITE
- Area of exposure: approx. 25 cm² for males and 18 cm² for females
- % coverage: approx. 10% of the total body surface
- Type of wrap if used: surgical gauze patch (Surgy 1D), successively covered with aluminum foil and Coban elastic bandage. A piece of Micropore tape was additionally used for fixation of the bandages in females only.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): with tap water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 mL/kg BW
- Concentration (if solution): 2000 mg/kg BW
- The formulation (w/w) was prepared within 4 hours prior to dosing. Homogeneity was accomplished to a visually acceptable level.
VEHICLE
- Amount(s) applied (volume or weight with unit):
- Concentration (if solution): 10 mL/kg BW - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg BW
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: mortality: twice daily; Body weights: Days 1 (pre-administration), 8 and 15; Clinical signs: At periodic intervals on the day of dosing (Day 1) and once daily thereafter, until Day 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- Not performed
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: Flat posture and chromodacryorrhoea were noted among the animals on Days 1 and/or 2. Piloerection was noted in all animals between Days 1 and 4. Scales and scabs were seen in the treated skin-area among the animals throughout the observation period.
- Gross pathology:
- No abnormalities were found at macroscopic post mortem examination of the animals.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The dermal LD50 value of TC4ASO2 in Wistar rats was established to exceed 2000 mg/kg body weight.
Based on these results TC4ASO2 does not have to be classified and has no obligatory labeling requirement for dermal toxicity according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations (2007) and EC criteria for classification and labeling requirements for dangerous substance and preparations (Council Directive 67/548/EEC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
